Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02694679 · ClinicalTrials.gov registry record · NA

Randomized Controlled Trial of Social Network Targeting in Honduras

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
31,195
Enrollment target

NCT02694679 is a NA study that has completed, run by Yale University. The registered enrollment target is 31,195 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02694679, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
31,195 participants
Enrollment target

Study Summary

Social network targeting strategies can be used to improve the delivery and uptake of health interventions. We will enroll approximately 30,000 individuals into a randomized controlled trial of different targeting algorithms in order to explore how social network dynamics affect the uptake, diffusion, and group-level normative reinforcement of key neonatal and infant health behaviors and attitudes in 176 rural villages in the Copan region of Honduras. Our goal is to develop methods by which global health practitioners can exploit face-to-face social network interactions in order to maximize uptake of neonatal and infant health interventions. The villages will be randomly assigned to 16 cells of 11 villages each in a 2 x 8 factorial design of different targeting algorithms.

Interventions

  • BEHAVIORAL CBNH

Trial Details

FieldValue
Enrollment Target 31,195 participants
Start Date 2015-06
Est. Completion 2020-01
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02694679

The ClinicalTrials.gov registry entry for NCT02694679 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31,195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CBNH is the first listed.

NCT02694679 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02694679 about?

NCT02694679 is a clinical study titled "Randomized Controlled Trial of Social Network Targeting in Honduras". Social network targeting strategies can be used to improve the delivery and uptake of health interventions. We will enroll approximately 30,000 individuals into a randomized controlled trial of different targeting algorithms in order to explore how social network dynamics affect the uptake, diffusio...

What is the current status of trial NCT02694679?

This trial is currently completed. It is a NA study. The enrollment target is 31,195 participants. The study started on 2015-06. Estimated completion is 2020-01.

What interventions are being tested in trial NCT02694679?

The interventions under investigation include: CBNH (BEHAVIORAL).

Who is sponsoring clinical trial NCT02694679?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.